Systematix Corporate Q2 FY26: Standalone PAT nearly triples YoY

Emphasis Of MatterRevenue Growth 20pctPat Growth 25pctGoing ConcernResults View source PDF Explain this filing

SYSTMTXC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹161.13

prior close

₹161.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-2.3% vs market

Stockbroking & Allied peers, median of 35sector+0.2%-1.6% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 1.6 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

-0.2

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3+0.9-2.3+0.2-1.6

Next day

-2.6+0.8-3.4+0.2-2.8

-6.8+0.7-7.6-0.3-6.6

-6.2+1.3-7.6-0.7-5.5

-4.1+0.5-4.7-0.6-3.6

-6.3+0.4-6.6-1.0-5.3

+2.1-1.5+3.6-2.0+4.1

15d

-3.2-2.4-0.7-1.4-1.8

-1.8-4.4+2.6-3.5+1.7

-32.9-7.2-25.7-9.1-23.9

-47.7-5.0-42.7-12.1-35.6

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 35Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q2 FY26: total income at Rs 39.97 cr versus Rs 18.09 cr YoY, up about 121 percent. Standalone profit after tax at Rs 17.99 cr versus Rs 5.98 cr, up around 201 percent. H1 standalone PAT at Rs 23.97 cr versus Rs 8.68 cr. Consolidated Q2 PAT at Rs 14.48 cr versus Rs 22.14 cr YoY, down about 35 percent on higher expenses. H1 consolidated PAT nearly flat at Rs 24.94 cr. Limited review report is clean but flags an Emphasis of Matter on subsidiary SCSPL where SEBI cancelled its registration; SAT has stayed the order. Company affirms going concern.

Likely market impact

Strong standalone earnings, but consolidated softness and unresolved regulatory action against subsidiary SCSPL remain key watchpoints for investors.